MedPath

湖南协力药业有限公司

Ownership
-
Established
1989-11-29
Employees
-
Market Cap
-
Website
http://www.qjxlyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

31

NMPA:31

Drug Approvals

Sacubitril Valsartan Sodium Tablets

Product Name
沙库巴曲缬沙坦钠片
Approval Number
国药准字H20254250
Approval Date
May 27, 2025
NMPA

蛇胆川贝液

Approval Number
国药准字Z43020476
Approval Date
Aug 14, 2024
NMPA

Berberine Hydrochloride Tablets

Product Name
盐酸小檗碱片
Approval Number
国药准字H43020313
Approval Date
Aug 14, 2024
NMPA

Berberine Hydrochloride Tablets

Product Name
盐酸小檗碱片
Approval Number
国药准字H43020312
Approval Date
Aug 14, 2024
NMPA

Dipyridamole tablets

Product Name
双嘧达莫片
Approval Number
国药准字H43020774
Approval Date
Aug 14, 2024
NMPA

Pipemidic Acid Tablets

Product Name
吡哌酸片
Approval Number
国药准字H43020303
Approval Date
Aug 14, 2024
NMPA

Berberine Hydrochloride Tablets

Product Name
盐酸小檗碱片
Approval Number
国药准字H43020311
Approval Date
Aug 14, 2024
NMPA

Pipemidic Acid Tablets

Product Name
吡哌酸片
Approval Number
国药准字H43020304
Approval Date
Aug 14, 2024
NMPA

Cimetidine Tablets

Product Name
西咪替丁片
Approval Number
国药准字H43020305
Approval Date
Aug 14, 2024
NMPA

Zinc Gluconate Tablets

Product Name
葡萄糖酸锌片
Approval Number
国药准字H43020309
Approval Date
Jul 3, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.